Correlation Between Cerevel Therapeutics and Apellis Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Cerevel Therapeutics and Apellis Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cerevel Therapeutics and Apellis Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cerevel Therapeutics Holdings and Apellis Pharmaceuticals, you can compare the effects of market volatilities on Cerevel Therapeutics and Apellis Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cerevel Therapeutics with a short position of Apellis Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cerevel Therapeutics and Apellis Pharmaceuticals.
Diversification Opportunities for Cerevel Therapeutics and Apellis Pharmaceuticals
-0.07 | Correlation Coefficient |
Good diversification
The 3 months correlation between Cerevel and Apellis is -0.07. Overlapping area represents the amount of risk that can be diversified away by holding Cerevel Therapeutics Holdings and Apellis Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Apellis Pharmaceuticals and Cerevel Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cerevel Therapeutics Holdings are associated (or correlated) with Apellis Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Apellis Pharmaceuticals has no effect on the direction of Cerevel Therapeutics i.e., Cerevel Therapeutics and Apellis Pharmaceuticals go up and down completely randomly.
Pair Corralation between Cerevel Therapeutics and Apellis Pharmaceuticals
Given the investment horizon of 90 days Cerevel Therapeutics Holdings is expected to under-perform the Apellis Pharmaceuticals. In addition to that, Cerevel Therapeutics is 1.28 times more volatile than Apellis Pharmaceuticals. It trades about -0.01 of its total potential returns per unit of risk. Apellis Pharmaceuticals is currently generating about 0.01 per unit of volatility. If you would invest 5,332 in Apellis Pharmaceuticals on September 3, 2024 and sell it today you would lose (1,790) from holding Apellis Pharmaceuticals or give up 33.57% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 83.03% |
| Values | Daily Returns |
Cerevel Therapeutics Holdings vs. Apellis Pharmaceuticals
Performance |
| Timeline |
| Cerevel Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Apellis Pharmaceuticals |
Cerevel Therapeutics and Apellis Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cerevel Therapeutics and Apellis Pharmaceuticals
The main advantage of trading using opposite Cerevel Therapeutics and Apellis Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cerevel Therapeutics position performs unexpectedly, Apellis Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Apellis Pharmaceuticals will offset losses from the drop in Apellis Pharmaceuticals' long position.| Cerevel Therapeutics vs. Avidity Biosciences | Cerevel Therapeutics vs. Revolution Medicines | Cerevel Therapeutics vs. Day One Biopharmaceuticals | Cerevel Therapeutics vs. SpringWorks Therapeutics |
| Apellis Pharmaceuticals vs. Akero Therapeutics | Apellis Pharmaceuticals vs. Immunovant | Apellis Pharmaceuticals vs. Madrigal Pharmaceuticals | Apellis Pharmaceuticals vs. Day One Biopharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |